Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bifidobacterium longum + enterococcus faecalis + lactobacillus acidophilus
- Development stage
- Unknown
- Lead developer
- Shanghai Xinyi Bailuda Pharmaceutical
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
BIFICO is a probiotic combination product consisting of live *Bifidobacterium longum*, *Enterococcus faecalis*, and *Lactobacillus acidophilus*. It is primarily indicated for the regulation of intestinal microflora and the treatment of symptoms associated with dysbiosis, such as diarrhea, constipation, and abdominal distension. By replenishing beneficial bacteria, BIFICO helps restore the balance of the gut microbiota and strengthens the intestinal mucosal barrier. In clinical research, BIFICO is being evaluated for its potential to accelerate liver function recovery in patients with hepatocellular carcinoma (HCC) undergoing hepatectomy. This effect is thought to be mediated through the gut-liver axis, where stabilization of the intestinal barrier reduces the translocation of bacteria and endotoxins that can exacerbate liver inflammation and impair regeneration. The product is manufactured by Shanghai Sine Pharmaceutical.
- Brand names
- BIFICOPeifeikang
- Other names
- Bifidobacterium longum, Enterococcus faecalis and Lactobacillus acidophilus combined, liveTriple live bacteria
Beyond the preview
Go deeper on bifidobacterium longum + enterococcus faecalis + lactobacillus acidophilus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bifidobacterium longum + enterococcus faecalis + lactobacillus acidophilus.